Edwards Lifesciences Corp - Edwards Lifesciences Outlines Growth ...
2024年12月4日 · Edwards Lifesciences Corporation (NYSE: EW) will discuss the company’s focused strategy for long-term sustainable growth, provide an update on its technology pipeline to serve more patients and share financial guidance today during its annual investor conference. Edwards enters 2025, its first full year as a purely structural heart company, in a strong …
Representative, Office - Job Details | Edwards Lifesciences
Job posting for Representative, Office. Innovation starts from the heart. Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives.
Representative, GA - Job Details | Edwards Lifesciences
Job posting for Representative, GA. Innovation starts from the heart. Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives.
Edwards’ SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued …
2024年11月25日 · LONDON--(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London Valves 2024 and simultaneously published in the Journal of the American College of Cardiology (JACC): Cardiovascular …
Search Jobs - Edwards Lifesciences
COVID Vaccination Requirement Notice. Edwards is committed to protecting our vulnerable patients and the healthcare providers who are treating them.
Field Clinical Specialist, GA / TN, TMTT - Job Details
Job posting for Field Clinical Specialist, GA / TN, TMTT.
Edwards Lifesciences - the leader in heart valves & hemodynamic ...
Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.
Edwards Lifesciences to Sell Critical Care to BD
2024年6月3日 · IRVINE, CA--(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX), in an all-cash transaction valued at $4.2 billion. With this agreement, Edwards is no longer pursuing the previously announced spin-off of …
Field Clinical Specialist, GA / TN, TMTT - Job Details
Job posting for Field Clinical Specialist, GA / TN, TMTT. COVID Vaccination Requirement Notice. Edwards is committed to protecting our vulnerable patients and the healthcare providers who are treating them.
Jobs | Edwards Lifesciences
Real jobs from real companies. Updated daily. Only verified, open positions at top companies. Edwards Lifesciences Veterans Jobs